Dr. MacCumber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
71 W 156th St
Ste 400
Harvey, IL 60426Phone+1 708-596-8710Fax+1 708-596-9820
Summary
- Dr. Mathew MacCumber is an ophthalmologist in Oak Park, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center, Rush Oak Park Hospital, AMITA Health Saint Joseph Hospital, Skokie Hospital, Advocate Illinois Masonic Medical Center, Glenbrook Hospital, Highland Park Hospital, AMITA Health Saints Mary & Elizabeth Medical Center Chicago, and Captain James A. Lovell Federal Health Care Center. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 29 years. He specializes in retinal disease and is experienced in cataract surgery, retina surgery, and vitreoretinal disease.
Education & Training
- Johns Hopkins UniversityResidency, Ophthalmology, 1991 - 1994
- MedStar Franklin Square Medical CenterInternship, Internal Medicine, 1990 - 1991
- Johns Hopkins University School of MedicineClass of 1988
Certifications & Licensure
- IL State Medical License 1996 - 2026
- CA State Medical License 2021 - 2025
- NC State Medical License 1994 - 1998
- MD State Medical License 1993 - 1997
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging Start of enrollment: 2008 Jan 01
- PIIR Study: Comparison of Genetic Tests for Age-Related Macular Degeneration Start of enrollment: 2012 Jan 01
Publications & Presentations
PubMed
- 45 citationsThe Real-World Effect of Intravitreous Anti–Vascular Endothelial Growth Factor Drugs on Intraocular Pressure: An Analysis Using the IRIS RegistryElizabeth A. Atchison, Kevin M. Wood, Cynthia Mattox, Catherine N. Barry, Flora Lum
Ophthalmology. 2018-05-01 - 66 citationsSafety Outcomes of Brolucizumab in Neovascular Age-Related Macular Degeneration: Results From the IRIS Registry and Komodo Healthcare Map.Arshad M. Khanani, Marco A. Zarbin, Mark R. Barakat, Thomas A. Albini, Peter K. Kaiser
JAMA Ophthalmology. 2021-11-24 - 422 citationsEndothelin in brain: receptors, mitogenesis, and biosynthesis in glial cellsMathew W. Maccumber, Christopher A. Ross, Solomon H. Snyder
Proceedings of the National Academy of Sciences of the United States of America. 1990-03-01
Press Mentions
- Clearside Biomedical Featured in Multiple Data Presentations at the 44th Virtual Annual Macula Society MeetingFebruary 8th, 2021
- Update on Retinal Research with the IRIS RegistryOctober 1st, 2018
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: